Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 medication, preclinical ADCs

.Operating system Therapies will provide on the NYSE American inventory swap this morning by means o...

ALX's waning CD47 response fee sends out sell spiraling down

.ALX Oncology's period 2 gastric cancer feedback rate has actually damaged. After viewing its CD47 b...

Ionis centers eye illness from targets of Roche-partnered possibility after records let down

.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has actually fallen short of requirem...

Biogen's chief executive officer pointed out no dangerous deals in 2023. He prepares to become vibrant

.While Biogen's pharma peers are actually seeking for late-stage assets along with little bit of ris...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Bio has actually been actually a biotech searching for a pipe after it junked its own lead p...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back liberties to a very early Alzheimer's ailment plan to Denali Therap...

Takeda water faucets new mind people oncology business-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant management hirings, firings a...

Vertex, hammered by AATD once more, falls 2 resources on throw away heap

.Vertex's try to address a rare hereditary health condition has reached yet another problem. The bio...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of staff

.Vir Medical's second-quarter incomes record had not been except large updates. The business accepte...

Galapagos pauses CAR-T cell treatment hearing over Parkinsonism situation

.Galapagos has actually paused registration in a test of a BCMA-directed CAR-T tissue treatment, pus...